OTCMKTS:PKPH Peak Pharmaceuticals (PKPH) Stock Price, News & Analysis $1.25 +0.33 (+35.14%) As of 07/3/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About Peak Pharmaceuticals Stock (OTCMKTS:PKPH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Peak Pharmaceuticals alerts:Sign Up Key Stats Today's Range$1.10▼$1.2550-Day Range$0.81▼$4.0052-Week Range$0.52▼$9.12Volume802 shsAverage Volume9,053 shsMarket Capitalization$490 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Peak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ. Read More Receive PKPH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Peak Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address PKPH Stock News HeadlinesAkari Therapeutics Merges with Peak Bio for GrowthNovember 9, 2024 | markets.businessinsider.comNetflix hit series Wednesday season 2 is a ‘cultural juggernaut’ that’s already breaking recordsNovember 4, 2024 | msn.comThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.July 4 at 2:00 AM | Brownstone Research (Ad)Phathom's Voquezna: A Breakthrough Drug Facing Marketing ChallengesSeptember 27, 2024 | seekingalpha.comThailand says mpox case recorded in traveller from AfricaAugust 22, 2024 | msn.comPharma stocks soar after WHO declares mpox public health emergencyAugust 20, 2024 | msn.comDaytime and early peak commissioningMay 2, 2024 | bbc.co.ukAkari Therapeutics Signs Merger-of-Equals with Peak BioMarch 5, 2024 | marketwatch.comSee More Headlines PKPH Stock Analysis - Frequently Asked Questions How have PKPH shares performed this year? Peak Pharmaceuticals' stock was trading at $1.07 on January 1st, 2025. Since then, PKPH shares have increased by 16.8% and is now trading at $1.25. How do I buy shares of Peak Pharmaceuticals? Shares of PKPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Peak Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some other companies that Peak Pharmaceuticals investors own include Ginkgo Bioworks (DNA), Jazz Pharmaceuticals (JAZZ), Medical Marijuana (MJNA), Altria Group (MO), OPKO Health (OPK), Growlife (PHOT) and RTX (RTX). Company Calendar Today7/04/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryCannabis Current SymbolOTCMKTS:PKPH CIK1452804 Webwww.peakpharma.com Phone(480) 659-6404FaxN/AEmployees1Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$160 thousand Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-159.55% Debt Debt-to-Equity RatioN/A Current Ratio0.15 Quick Ratio0.15 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares392,000Free Float320,000Market Cap$423.36 thousand OptionableNot Optionable Beta0.54 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (OTCMKTS:PKPH) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Peak Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Peak Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PKPH Stock Alerts